🇺🇸 TG Therapeutics, Inc.
Forum topic · TGTX · Company page: financials, ownership and filings
Join the discussion on TG Therapeutics, Inc.
Loading…
Results announced on 9 November 2026
TG Therapeutics, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $260 million (up 61% from a year earlier) and net income of $55 million (down 86% from a year earlier).
Mutual funds: 252 funds hold $2.8 billion
252 mutual funds in 2 countries hold shares of TG Therapeutics, Inc. worth $2.8 billion, about 35.7% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 141 funds added shares and 85 sold; on balance they bought $72 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.